期刊文献+

喹诺酮药物的定量结构-活性关系 被引量:1

Quantitative structure-activity relationship study for quinolones.
下载PDF
导出
摘要 喹诺酮类抗菌素是一类重要的抗菌药物.本文对32个喹诺酮类分子进行了HF/6-31G*水平的结构优化,在优化结构上获得了分子的表面静电势分布,并在此基础上对其统计导出的参数进行了计算,同时计算了反映三维信息的3D-Morse参数,其后,运用多元线性回归方法对喹诺酮分子抑制金黄色葡萄球菌DNA促旋酶(QR-gy-rase)活性、人类Ⅱ型拓扑异构酶(TOPO-Ⅱ)的抑制活性、以及二者抑制活性之差与分子的结构参数进行了关联.结果表明:分子静电势参数结合三维3D-Morse参数可以很好地用于喹诺酮类化合物抑制DNA促旋酶、TOPO-Ⅱ活性与分子结构间的定量关系,并能有效地区分抑制两种酶的活性;同时结合3D-Morse参数的静电势参数被成功应用到定量结构-活性关系研究中. The quinolone is an important kind of antibacterial agents. Ab initio calculations were performed for all 32 quinolones at the HF/6-31G* level. Electrostatic potentials and subsequently derived statistically-based structural descriptors, the 3D-Morse descriptors were obtained. Linear relationships between the inhibition of OR-gyrase, TOPO- Ⅱ and theoretical descriptors were established by multiple regression method. It appeared that the quantities derived from electrostatic potentials, together with the 3D-Morse descriptors can be well used to express the quanti- tative structure-activity relationships of quinolones. And the models could identify how the structure of the molecules in question could be modified to produce good inhibition of gyrase and simultaneously reduce inhibition of TO- PO-Ⅱ. Moreover, the electrostatic potentials parameter together with 3D-Morse descriptors were successful applied in the QSAR study.
出处 《浙江大学学报(理学版)》 CAS CSCD 北大核心 2009年第1期62-68,73,共8页 Journal of Zhejiang University(Science Edition)
基金 宁波市重点实验室开放基金资助项目(2007A22003) 宁波市自然科学基金资助项目(2008A610045)
关键词 喹诺酮 定量结构-活性关系 分子静电势 quinolone quantitative structure-activity relationship molecular electrostatic potential
  • 相关文献

参考文献6

二级参考文献104

  • 1胡桂香,俞庆森.基于VolSurf参数的化合物水溶性QSPR分析[J].浙江大学学报(理学版),2004,31(6):661-666. 被引量:1
  • 2胡桂香,邹建卫,曾敏,张兵,金海晓,俞庆森.化合物膜水分配系数的QSPR研究和分子三维参数表征[J].浙江大学学报(理学版),2005,32(5):558-561. 被引量:3
  • 3Dong D C,Can J Chem,1984年,62卷,2560页
  • 4Winneke, G.; Walkowiak, J.; Lilienthal, H. Toxicology, 2002, 181:161.
  • 5Wang, X.; Tang, S.; Liu, S.; Cui, S.; Wang, L. Chemosphere, 2003, 51:617.
  • 6Staikova, M.; Wania, F.; Donaldson, D.J. Atom. Environ., 2004, 38:213.
  • 7Hansen, B.G.; Paya-Perez, A.B.; Rahman, M.; Larsen, B.R.Chemosphere, 1999, 39:2209.
  • 8Gramatica, P.; Navas, N.; Todeschini, R. Chemom. Intel. Lab. Sys., 1998, 40:53.
  • 9Puri, S.; Chickos, J.S.; Welsh, W.J. J. Chem. Inf. Comput. Sci., 2002, 42:109.
  • 10Zou, J.W.; Zhao, W.N.; Shang, Z.C.; Huang, M.L.; Guo, M.; Yu,Q.S. J. Phys. Chem. A, 2002, 106:11550.

共引文献50

同被引文献13

  • 1王红青,胡桂香,俞庆森,邹建卫.在CDMPC固定相上拆分的两个体系的HQSAR研究[J].浙江大学学报(理学版),2006,33(5):548-552. 被引量:3
  • 2LING P,NGO K,NGUYEN S,et al.Histamine H4 receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule upregulation[J].Br J Pharmacol,2004,142:161-171.
  • 3SUGATA Y,OKANO M,FUJIWARA T,et al.Histamine H4 receptor agonists have more activities than H4 agonism in antigen-specific human T-cell responses[J].Immuno-l,2007,121:266-275.
  • 4ESCH I,THURMOND R,JONGEJAN A,et al.The histamine H4 receptor as a new therapeutic target for inflammation[J].Trends Pharmacol Sci,2005,9(26):462-469.
  • 5ALTSCCHUL F,GISH W,MILLER W,et al.Basic local alignment search tool[J].J of Molecular Biology,1990,3(215):403-410.
  • 6ALTENBACH R,ADAIR R,BETTENCOURT B,et al.Structure-activity studies on a series of a 2-aminopyrimidine-containing histamine H4 receptor ligands[J].J Med Chem,2008,51:6571-6580.
  • 7KISS R M,KESERU G.Histamine H4 receptor ligands and their potential therapeutic applications[J].Expert Opin Ther Pat,2009,2(19):119-135.
  • 8ZAMPELI E,TILIGADA E.The role of histamine H4 receptor in immune and inflammatory disorders[J].Br J Pharmacol,2009,157:24-33.
  • 9REY S,CARON G,ERMONDI G,et al.Development of molecular hydrogenbonding potentials(MHBPs) and their application to structure-permeation relations[J].J Mol GraphicsModell,2001,6(19):521-535.
  • 10SYBYL Molecular Modelling Softwate,Version 6.8.Tripos:St.Louis,MO,2001.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部